Early intervention in the treatment of rheumatoid arthritis: focus on tocilizumab.

Ther Clin Risk Manag · 2013 · PMC3810895 · PMID 24179334

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significanceP =0.1so close (0.05 < p ≤ 0.1)

At 6 months, TCZ monotherapy showed higher rates of DAS28-C-reactive protein remission (76.5%) compared to MTX treatment (41.7%), although it did not reach statistical significance ( P =0.1).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.